Form D · Pharmaceuticals

Pono Life Sciences, LLC

Honolulu, HI · CIK 0001669977

Offering snapshot reported May 13, 2016 · SEC filing

Reported sold: $5.27M
Investors reported: 18
Minimum accepted: $0
First sale: May 13, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 13, 2016	Initial	$5,272,500	No comparison	18	SEC filing
May 13, 2016	Amendment	$5,272,500	$0vs May 13, 2016	18	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $385K (estimated)
Finders' fees: $0
Form D file number: 021-263159

Original total offering amount of $5,000,000 had up to a 10% over-allotment, as needed ($5,500,000). $5,272,500 was actually sold. $0 total remains to be sold.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Axiom Capital Management, Inc.	26580

Source: Form D, filed May 13, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Racquel Bueno	Director
William Farley	Director
Darrell Lee	Director
Sean Tadaki	Director
Michael Takano	Director, Executive
Greg Wood	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

1088 Bishop Street Suite 4100
Honolulu, HI, 96813